Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Regulations’), Laurus Labs has informed that Analyst/Institutional Investor meeting is scheduled on March 13, 2023 with Motilal Oswal in the form of In-Person Meetings. No Unpublished Price Sensitive Information will be shared during the meetings
The above information is a part of company’s filings submitted to BSE.